Nexelis, a Q² Solutions Company Revenue
Pharmaceutical Manufacturing • 
Laval, Quebec, Canada • 101-200 Employees
Nexelis, a Q² Solutions Company revenue & valuation
| Annual revenue | $14,000,000 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $44,700,000 |
| Total funding | No funding |
Key Contacts at Nexelis, a Q² Solutions Company
Danielle Poirier
Director Env Health & Safety/ Biosafety Officer
Gaye Martin
Sr. Director, Customer Solutions
Mark V. Sobolewski
Senior Director Customer Solutions
Martine Boyer
Director, Protein Sciences
Valérie Gauthier
Associate Director Specimen Management
Chantal Arguin
Director, Lab Operations Virology
Tania Gensale
Director Bacteriology Operations
Marie-France Robitaille
Director Project Management
Steven Tran
Director Lba & Cmi
Timothy Carlson
Director Of Biomarker Innovation & Laboratory Services
Company overview
| Headquarters | 525 Cartier West Blvd, Laval, Québec H7V 3S8, CA |
| Website | |
| NAICS | 3254 |
| Keywords | Molecular Biology, Ligand Binding Assays, Immuno-Oncology, Bioanalytical Services, Preclinical Services, Immunogenicity, Immunogenicity Testing, Novel Biomarker Assay Development, Animal Study Design, Cellular Immunology, Fit-For-Purpose Biomarkers, Functional Viral And Bacterial Assays, Immunochemistry Assays, In Vivo Study Approaches, Pharmacokinetic Testing, Protein Services, In Vitro Models, Study Readouts, Lc/Ms Hrlc/Ms |
| Founded | 1989 |
| Employees | 101-200 |
| Socials |
Nexelis, a Q² Solutions Company Email Formats
Nexelis, a Q² Solutions Company uses 5 email formats. The most common is {first name}.{last name} (e.g., john.doe@nexelis.com), used 59.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@nexelis.com | 59.6% |
{first initial}.{last name} | j.doe@nexelis.com | 26.3% |
{first name}{last name} | johndoe@nexelis.com | 8.8% |
{first initial}.{first initial} | j.j@nexelis.com | 1.8% |
{first initial}{last name} | jdoe@nexelis.com | 1.8% |
About Nexelis, a Q² Solutions Company
With unrivaled expertise in immunology, 5 operating sites in North America and Europe, and a translational offer of services covering the needs of the pharmaceutical industry from the lead selection to the late clinical stage, Nexelis, a Q² Solutions Company, is a leading provider of assay development and advanced laboratory testing services in the infectious, metabolic and oncologic fields. Our versatile team of scientists, working with state of the art technology platforms, were instrumental in the development, qualification, validation, and large-scale sample testing of assays that supported the FDA filing of almost 350 new molecular entities, including blockbuster vaccines and biologics, anti-viral drugs, immunotherapy, gene and cell therapy products.
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Nexelis, a Q² Solutions Company has 37 employees across 9 departments.
Departments
Number of employees
Funding Data
Nexelis, a Q² Solutions Company has never raised funding before.
Nexelis, a Q² Solutions Company Tech Stack
Discover the technologies and tools that power Nexelis, a Q² Solutions Company's digital infrastructure, from frameworks to analytics platforms.
Security
Issue trackers
CMS
JavaScript libraries
JavaScript libraries
JavaScript libraries
Reverse proxies
JavaScript libraries
CDN
Web servers
Search engines
Argentina
South Africa
New Zealand
NorwayFrequently asked questions
4.8
40,000 users
